Related Experiment Video

Updated: Jun 1, 2026

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

IgM multiple myeloma: more on a rare and heterogeneous disease

Quentin Cabrera, Sylvain Chantepie, Veronique Salaun

    American Journal of Hematology
    |June 2, 2011
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
    07:53

    Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

    Published on: April 15, 2022

    Related Experiment Videos

    Last Updated: Jun 1, 2026

    Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
    05:32

    Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

    Published on: January 7, 2019

    Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
    07:53

    Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

    Published on: April 15, 2022

    Related Concept Videos

    Multiple Sclerosis l: Introduction01:19

    Multiple Sclerosis l: Introduction

    Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

    Articles linked to this work by shared authors, journal, and citation graph.

    Daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: MAIA final survival analysis.

    Leukemia·2026

    Lung cysts, a common feature found in patients with hairy cell leukaemia and Langerhans cell histiocytosis.

    ERJ open research·2026

    Comparison of patient, hospitalization and center characteristics from the EMMY centers, IFM centers, and all multiple myeloma centers in France.

    Clinical hematology international·2026

    Burden, cognitive complaints, and supportive needs in dyads of older patients with hematological malignancy and their primary caregivers: A cross-sectional multicenter study.

    Journal of geriatric oncology·2026

    Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement.

    Leukemia·2026

    A dexamethasone-free daratumumab-ixazomib regimen in frail elderly patients with relapsed or refractory multiple myeloma: Results of the IFM 2018-02 phase II study.

    British journal of haematology·2026

    HOPE Kids 2: Phase 3, Randomized Trial of Voxelotor in Children With SCD and Conditional Cerebral Blood Flow Velocities.

    American journal of hematology·2026

    Targeting B-Cell-Activating Factor and Its Receptor in Immune Thrombocytopenia and Warm Autoimmune Hemolytic Anemia.

    American journal of hematology·2026

    Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).

    American journal of hematology·2026

    SHR-2004, a Humanized Monoclonal Antibody Targeting Factor XI, for Preventing Venous Thromboembolism After Ovarian Cancer Surgery: A Randomized, Active-Controlled Phase 2 Study.

    American journal of hematology·2026

    Chromosome 1q Gain Defines a Plasma Cell-Dominant Adverse-Risk Subtype in AL Amyloidosis With Inferior Long-Term Survival.

    American journal of hematology·2026

    Myeloma Elderly Prognostic Score (MEPS): A Proposed Prognostic Score Integrating Age, Renal Function, Performance Status, and Ultra-High-Risk Cytogenetics.

    American journal of hematology·2026

    Endobronchial lipoma presenting as a fat-attenuation lesion causing left upper lobar bronchial obstruction: A case report.

    Radiology case reports·2026

    Immunomodulation of microglia/macrophages and neutrophils as immunotherapeutic targets in ischemic stroke: A narrative review.

    Brain circulation·2026

    Kidney Allograft Outcomes in Borderline and T Cell-Mediated Rejection With Microvascular Inflammation.

    Kidney international reports·2026

    Overlap Myositis in a Patient With Psoriasis Treated With Anti-TNF-Alpha Therapy: A Case Report and Review of Literature.

    Case reports in rheumatology·2026

    Case Report: From idiopathic recurrent pericarditis to systemic Behçet's Disease: unmasking a unified IL-1-driven autoinflammatory phenotype.

    Frontiers in immunology·2026

    Lower invasiveness of papillary thyroid carcinoma associated with Hashimoto's thyroiditis: evidence from AJCC 8th-edition stratification and a dose-response relationship with autoantibody titers.

    Frontiers in endocrinology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us